Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein O-mannosyl-transferase 2 (POMT2) is an enzyme encoded by the POMT2 gene, which forms part of the protein O-mannosyltransferase complex with POMT1. This complex is an integral membrane protein located in the endoplasmic reticulum and catalyzes the transfer of mannose to serine or threonine residues of target proteins, with α-dystroglycan being a critical substrate. Glycosylation by the POMT complex is essential for α-dystroglycan function, which anchors the cytoskeleton to the extracellular matrix, stabilizes muscle fibers, and controls neuronal migration during development. Mutations in the POMT2 gene cause various congenital muscular dystrophies, including the severe Walker-Warburg syndrome, due to impaired glycosylation of α-dystroglycan, which leads to destabilized muscle fibers and abnormal brain and eye development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein O-mannosyl-transferase 2 (POMT2).